Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (830)
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,373
Price
$276.17
Total Value
$655.34K
Shares Held After
73,293
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
9,430
Price
$275.45
Total Value
$2.60M
Shares Held After
75,666
% of Holdings
11.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$480.31
Total Value
$1.12M
Shares Held After
37,734
% of Holdings
5.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
3,325
Price
$27.95
Total Value
$92.93K
Shares Held After
143,678
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
182,891
Price
$15.99
Total Value
$2.92M
Shares Held After
2,276,354
% of Holdings
7.4%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,761
Price
$45.72
Total Value
$171.97K
Shares Held After
10,503
% of Holdings
26.4%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,739
Price
$45.13
Total Value
$168.76K
Shares Held After
14,264
% of Holdings
20.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
1,725
Price
$496.95
Total Value
$857.24K
Shares Held After
98,278
% of Holdings
1.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
5,995
Price
$496.16
Total Value
$2.97M
Shares Held After
100,003
% of Holdings
5.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
15,580
Price
$495.38
Total Value
$7.72M
Shares Held After
105,998
% of Holdings
12.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
3,498
Price
$494.33
Total Value
$1.73M
Shares Held After
121,578
% of Holdings
2.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,520
Price
$493.29
Total Value
$1.24M
Shares Held After
125,076
% of Holdings
2.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
949
Price
$491.30
Total Value
$466.24K
Shares Held After
127,596
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,725
Price
$490.54
Total Value
$1.34M
Shares Held After
128,545
% of Holdings
2.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
460
Price
$489.32
Total Value
$225.09K
Shares Held After
131,270
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
3,278
Price
$488.27
Total Value
$1.60M
Shares Held After
131,730
% of Holdings
2.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,510
Price
$487.13
Total Value
$1.22M
Shares Held After
135,008
% of Holdings
1.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
240
Price
$482.84
Total Value
$115.88K
Shares Held After
137,518
% of Holdings
0.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
120
Price
$481.50
Total Value
$57.78K
Shares Held After
137,758
% of Holdings
0.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
400
Price
$479.75
Total Value
$191.90K
Shares Held After
137,878
% of Holdings
0.3%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
400
Price
$10.86
Total Value
$4.34K
Shares Held After
22,006
% of Holdings
1.8%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
10,900
Price
$67.84
Total Value
$739.50K
Shares Held After
7,465
% of Holdings
59.4%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
14,584
Price
$67.08
Total Value
$978.28K
Shares Held After
18,365
% of Holdings
44.3%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,117
Price
$190.91
Total Value
$213.24K
Shares Held After
9,235
% of Holdings
10.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
140
Price
$334.39
Total Value
$46.81K
Shares Held After
22,129
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
942
Price
$332.48
Total Value
$313.20K
Shares Held After
22,269
% of Holdings
4.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
1,159
Price
$331.49
Total Value
$384.20K
Shares Held After
23,211
% of Holdings
4.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
2,259
Price
$330.73
Total Value
$747.12K
Shares Held After
24,370
% of Holdings
8.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
127
Price
$328.92
Total Value
$41.77K
Shares Held After
26,629
% of Holdings
0.5%
Jazz Pharmaceuticals plc (JAZZ)
RIEDEL NORBERT G — Director
Shares
3,415
Price
$192.00
Total Value
$655.68K
Shares Held After
7,024
% of Holdings
32.7%
UNITED THERAPEUTICS Corp (UTHR)
Olian Judy D. — Director
Shares
200
Price
$509.55
Total Value
$101.91K
Shares Held After
4,845
% of Holdings
4.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Dunn Edmund — Principal Accounting Officer
Shares
25,164
Price
$18.10
Total Value
$455.51K
Shares Held After
22,693
% of Holdings
52.6%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
9,406
Price
$3.01
Total Value
$28.31K
Shares Held After
173,999
% of Holdings
5.1%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
4,800
Price
$25.11
Total Value
$120.53K
Shares Held After
109,843
% of Holdings
4.2%
ARVINAS, INC. (ARVN)
Houston John G — Director
Shares
11,787
Price
$13.14
Total Value
$154.88K
Shares Held After
1,122,183
% of Holdings
1.0%
ARVINAS, INC. (ARVN)
Houston John G — Director
Shares
18,822
Price
$13.24
Total Value
$249.20K
Shares Held After
1,133,970
% of Holdings
1.6%
ARVINAS, INC. (ARVN)
Houston John G — Director
Shares
4,688
Price
$13.24
Total Value
$62.07K
Shares Held After
1,152,792
% of Holdings
0.4%
Arcellx, Inc. (ACLX)
Elghandour Rami — Director
Shares
89,916
Price
$113.92
Total Value
$10.24M
Shares Held After
276,051
% of Holdings
24.6%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,253
Price
$194.11
Total Value
$243.22K
Shares Held After
10,352
% of Holdings
10.8%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
200
Price
$103.96
Total Value
$20.79K
Shares Held After
59,634
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
2,602
Price
$103.41
Total Value
$269.07K
Shares Held After
59,834
% of Holdings
4.2%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
2,698
Price
$102.64
Total Value
$276.92K
Shares Held After
62,436
% of Holdings
4.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
357
Price
$483.36
Total Value
$172.56K
Shares Held After
6,624
% of Holdings
5.1%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
197
Price
$193.60
Total Value
$38.14K
Shares Held After
58,818
% of Holdings
0.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,009
Price
$192.79
Total Value
$194.53K
Shares Held After
59,015
% of Holdings
1.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,784
Price
$191.88
Total Value
$342.31K
Shares Held After
60,024
% of Holdings
2.9%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
549
Price
$190.80
Total Value
$104.75K
Shares Held After
61,808
% of Holdings
0.9%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,061
Price
$190.00
Total Value
$201.59K
Shares Held After
62,357
% of Holdings
1.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
3,523
Price
$193.58
Total Value
$681.99K
Shares Held After
63,418
% of Holdings
5.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
11,529
Price
$191.65
Total Value
$2.21M
Shares Held After
66,941
% of Holdings
14.7%
Showing 1–50 of 830 transactions (page 1 of 17)